PRImary Care Strategies for Weight Management (PRISM) Study
ConditionObesity
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorRush University Medical Center
About this trial
The goal of this clinical trial pilot is to determine the feasibility of an intervention to enhance weight management in patients who have stopped taking anti-obesity/weight management medications in primary care. The main questions it aims to answer are:
* Can patients be recruited into the study efficiently? * Is the program acceptable to patients? * Can the study be conducted efficiently?
The new program will be compared to usual care.
Eligibility criteria
Qualifiers
For run-in: prescribed liraglutide, semaglutide, or tirzepatide or newer medication approved by the FDA for long-term use for obesity treatment for the purpose of weight managment by a primary care provider at Rush University System for Health and have received at least one dose of the medication concurrent with enrollment in the study.
For randomization: discontinue their prescribed anti-obesity medication.
Age 18+
Disqualifiers
Not fluent in English
Diagnosis of diabetes (type 1 or type 2)
Current or planned pregnancy
Bariatric surgery in the past 2 years or planned bariatric surgery.
Trial design
Treatments tested in this trial
- PRISM Program
Treatment groups
214 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov